ID

17415

Beschrijving

Safety and Efficacy Study of RENEWAL 4 AVT; ODM derived from: https://clinicaltrials.gov/show/NCT00180336

Link

https://clinicaltrials.gov/show/NCT00180336

Trefwoorden

  1. 12-09-16 12-09-16 -
Geüploaded op

12 september 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Heart Failure NCT00180336

Eligibility Heart Failure NCT00180336

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
indications for the device
Beschrijving

Indication Medical Device

Datatype

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0025080
availability for follow-up at an approved field following center, at the protocol defined intervals
Beschrijving

Study Protocol Interval Follow-up Availability

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C1272706
UMLS CUI [1,3]
C3274571
UMLS CUI [1,4]
C0470187
willing and capable of undergoing a device implant and participating in all testing associated with this clinical investigation
Beschrijving

Device implant Willing | Testing participation

Datatype

boolean

Alias
UMLS CUI [1,1]
C0948629
UMLS CUI [1,2]
C0600109
UMLS CUI [2,1]
C0039593
UMLS CUI [2,2]
C0679823
prescribed to stable optimal pharmacologic therapy for hf
Beschrijving

Heart failure Pharmacotherapy Optimal Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0013216
UMLS CUI [1,3]
C2698651
UMLS CUI [1,4]
C0205360
age 18 or above, or of legal age to give informed consent specific to national law
Beschrijving

Age | Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
able to provide documented evidence of one or more episodes of af/at within 12 months of implantation note: guidant recommends anticoagulation therapy per physician discretion.
Beschrijving

Atrial Fibrillation Episode Quantity Evidence | Atrial Tachyarrhythmia Episode Quantity Evidence | Anticoagulation Therapy Recommended

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0332189
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0332120
UMLS CUI [2,1]
C0080203
UMLS CUI [2,2]
C0018792
UMLS CUI [2,3]
C0332189
UMLS CUI [2,4]
C1265611
UMLS CUI [2,5]
C0332120
UMLS CUI [3,1]
C0003281
UMLS CUI [3,2]
C0034866
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
right bundle branch block morphology
Beschrijving

Right bundle branch block Morphology

Datatype

boolean

Alias
UMLS CUI [1,1]
C0085615
UMLS CUI [1,2]
C0332437
life expectancy of less than six months due to other medical conditions
Beschrijving

Life Expectancy Due to Other medical condition

Datatype

boolean

Alias
UMLS CUI [1,1]
C0023671
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C3843040
expectation of a heart transplant during the period of the study
Beschrijving

Heart Transplantation Expected

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018823
UMLS CUI [1,2]
C1517001
patients with or who are likely to receive a mechanical tricuspid valve during the course of the study
Beschrijving

Mechanical heart valve prosthesis Tricuspid valve

Datatype

boolean

Alias
UMLS CUI [1,1]
C3873910
UMLS CUI [1,2]
C0040960
have a preexisting unipolar pacemaker that will not be explanted/abandoned
Beschrijving

Artificial cardiac pacemaker Unipolar Pre-existing

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030163
UMLS CUI [1,2]
C0443340
UMLS CUI [1,3]
C2347662
have an atrial tachyarrhythmia that is permanent (i.e., does not terminate spontaneously and cannot be terminated with medical intervention) within 180 days prior to enrollment
Beschrijving

Atrial Tachyarrhythmia Permanent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0080203
UMLS CUI [1,2]
C0018792
UMLS CUI [1,3]
C0205355
have a known hypersensitivity to dexamethasone acetate
Beschrijving

Hypersensitivity dexamethasone acetate

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0057598
enrolled in any other study, including drug investigation
Beschrijving

Study Subject Participation Status | Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
women that are pregnant or planning to become pregnant
Beschrijving

Pregnancy | Pregnancy, Planned

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
a cerebral vascular event/ transient ischemic attack within 12 months of implantation
Beschrijving

Cerebrovascular accident | Transient Ischemic Attack

Datatype

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007787
during the four weeks prior to implantation, a patient experiences an episode of af >= 48 hours in duration and was not anticoagulated for at an adequate therapeutic level (inr >= 2.0) for the 4 weeks prior to enrollment
Beschrijving

Atrial Fibrillation Episode Duration | Anticoagulation Therapy Inadequate | International Normalized Ratio

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0332189
UMLS CUI [1,3]
C0449238
UMLS CUI [2,1]
C0003281
UMLS CUI [2,2]
C0205412
UMLS CUI [3]
C0525032

Similar models

Eligibility Heart Failure NCT00180336

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Indication Medical Device
Item
indications for the device
boolean
C3146298 (UMLS CUI [1,1])
C0025080 (UMLS CUI [1,2])
Study Protocol Interval Follow-up Availability
Item
availability for follow-up at an approved field following center, at the protocol defined intervals
boolean
C2348563 (UMLS CUI [1,1])
C1272706 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,4])
Device implant Willing | Testing participation
Item
willing and capable of undergoing a device implant and participating in all testing associated with this clinical investigation
boolean
C0948629 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0039593 (UMLS CUI [2,1])
C0679823 (UMLS CUI [2,2])
Heart failure Pharmacotherapy Optimal Stable
Item
prescribed to stable optimal pharmacologic therapy for hf
boolean
C0018801 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C2698651 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
Age | Informed Consent
Item
age 18 or above, or of legal age to give informed consent specific to national law
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Atrial Fibrillation Episode Quantity Evidence | Atrial Tachyarrhythmia Episode Quantity Evidence | Anticoagulation Therapy Recommended
Item
able to provide documented evidence of one or more episodes of af/at within 12 months of implantation note: guidant recommends anticoagulation therapy per physician discretion.
boolean
C0004238 (UMLS CUI [1,1])
C0332189 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0332120 (UMLS CUI [1,4])
C0080203 (UMLS CUI [2,1])
C0018792 (UMLS CUI [2,2])
C0332189 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C0332120 (UMLS CUI [2,5])
C0003281 (UMLS CUI [3,1])
C0034866 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Right bundle branch block Morphology
Item
right bundle branch block morphology
boolean
C0085615 (UMLS CUI [1,1])
C0332437 (UMLS CUI [1,2])
Life Expectancy Due to Other medical condition
Item
life expectancy of less than six months due to other medical conditions
boolean
C0023671 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
Heart Transplantation Expected
Item
expectation of a heart transplant during the period of the study
boolean
C0018823 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
Mechanical heart valve prosthesis Tricuspid valve
Item
patients with or who are likely to receive a mechanical tricuspid valve during the course of the study
boolean
C3873910 (UMLS CUI [1,1])
C0040960 (UMLS CUI [1,2])
Artificial cardiac pacemaker Unipolar Pre-existing
Item
have a preexisting unipolar pacemaker that will not be explanted/abandoned
boolean
C0030163 (UMLS CUI [1,1])
C0443340 (UMLS CUI [1,2])
C2347662 (UMLS CUI [1,3])
Atrial Tachyarrhythmia Permanent
Item
have an atrial tachyarrhythmia that is permanent (i.e., does not terminate spontaneously and cannot be terminated with medical intervention) within 180 days prior to enrollment
boolean
C0080203 (UMLS CUI [1,1])
C0018792 (UMLS CUI [1,2])
C0205355 (UMLS CUI [1,3])
Hypersensitivity dexamethasone acetate
Item
have a known hypersensitivity to dexamethasone acetate
boolean
C0020517 (UMLS CUI [1,1])
C0057598 (UMLS CUI [1,2])
Study Subject Participation Status | Investigational New Drugs
Item
enrolled in any other study, including drug investigation
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Pregnancy | Pregnancy, Planned
Item
women that are pregnant or planning to become pregnant
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Cerebrovascular accident | Transient Ischemic Attack
Item
a cerebral vascular event/ transient ischemic attack within 12 months of implantation
boolean
C0038454 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
Atrial Fibrillation Episode Duration | Anticoagulation Therapy Inadequate | International Normalized Ratio
Item
during the four weeks prior to implantation, a patient experiences an episode of af >= 48 hours in duration and was not anticoagulated for at an adequate therapeutic level (inr >= 2.0) for the 4 weeks prior to enrollment
boolean
C0004238 (UMLS CUI [1,1])
C0332189 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0003281 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
C0525032 (UMLS CUI [3])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial